These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1981890)

  • 41. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-performance liquid chromatographic assay for determination of a new beta-blocking agent FM 24.
    Lefebvre MA; Julian B; Fourtillan JB
    J Chromatogr; 1982 Jun; 230(1):199-202. PubMed ID: 6125522
    [No Abstract]   [Full Text] [Related]  

  • 43. Bioanalysis of the investigational anti-tumour drug 5,10-dideaza-5,6,7,8-tetrahydrofolic acid by high-performance liquid chromatography with ultraviolet detection.
    van Tellingen O; Sips JH; Beijnen JH; Schornagel JH; Nooyen WJ
    J Chromatogr; 1992 Apr; 576(1):158-62. PubMed ID: 1500451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
    Donnelly R; Macphee GJ
    Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.
    Given BD; Perentesis G; Christopher JD; Herron J; Patrick JE; Kramer WG; Affrime MB
    Am J Cardiol; 1989 Jun; 63(19):12I-16I. PubMed ID: 2729123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism.
    Sybertz EJ; Watkins RW
    Am J Cardiol; 1989 Jun; 63(19):3I-6I. PubMed ID: 2567112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents.
    Barbato F; Caliendo G; La Rotonda MI; Morrica P; Silipo C; Vittoria A
    Farmaco; 1990 Jun; 45(6):647-63. PubMed ID: 1980191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-performance liquid chromatographic determination of the enantiomers of beta-adrenoceptor blocking agents in biological fluids. II. Studies with atenolol.
    Chin SK; Hui AC; Giacomini KM
    J Chromatogr; 1989 Apr; 489(2):438-45. PubMed ID: 2568994
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitive high-performance liquid chromatographic method for procaterol in human urine.
    Wright DS; Pachla LA; Gibson DM; Jordan RA
    J Chromatogr; 1987 Jun; 417(1):223-8. PubMed ID: 2887580
    [No Abstract]   [Full Text] [Related]  

  • 51. Determination of the beta-adrenoceptor blocking drug B24/76 in serum by high-performance liquid chromatography with fluorimetric detection after pre-column dansylation.
    Zschiesche M; Baumann A
    J Chromatogr; 1989 Mar; 488(2):482-6. PubMed ID: 2568366
    [No Abstract]   [Full Text] [Related]  

  • 52. High-performance liquid chromatographic method for the determination of carazolol in serum or plasma of pigs.
    Kadir F; Zuidema J
    J Chromatogr; 1990 May; 527(2):461-6. PubMed ID: 1974898
    [No Abstract]   [Full Text] [Related]  

  • 53. High-performance liquid chromatographic analysis of pentoxifylline and 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine in whole blood.
    Grasela DM; Rocci ML
    J Chromatogr; 1987 Aug; 419():368-74. PubMed ID: 3667793
    [No Abstract]   [Full Text] [Related]  

  • 54. High-performance liquid chromatographic method for the simultaneous determination of R-(-)- and S-(+)-hexobarbital in rat plasma.
    Vermeulen AM; Rosseel MT; Belpaire FM
    J Chromatogr; 1991 Jul; 567(2):472-9. PubMed ID: 1939480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization.
    Maurer HH; Tenberken O; Kratzsch C; Weber AA; Peters FT
    J Chromatogr A; 2004 Nov; 1058(1-2):169-81. PubMed ID: 15595665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW; Sybertz EJ; Cook J; Pula K; Cedeno K; Tedesco RP; McLeod R
    Arch Int Pharmacodyn Ther; 1989; 302():158-73. PubMed ID: 2576892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radioreceptor assay for serum levels of cetamolol, a new beta-adrenoceptor antagonist.
    Stern MD
    Clin Biochem; 1984 Jun; 17(3):162-5. PubMed ID: 6145529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of the efficacy and safety of dilevalol in the treatment of essential arterial hypertension].
    Bochicchio T; Pérez-Grovas HA; Carrizosa J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1989; 59(2):181-6. PubMed ID: 2569857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of (E)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2- phenylethenyl) naphthalene, an antiacne agent, and its phenolic metabolite in plasma by reversed-phase high-performance liquid chromatography.
    Puglisi CV; Chen S; Stelling-Ferrara M; Pao J; Bekersky I
    J Chromatogr; 1987 Aug; 419():253-62. PubMed ID: 2959673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.